Menu

FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

    Print this page.

expand all

1.24.2014 Proportion of Days Covered by Medications (PDC) The Oral Diabetes Tab includes the NDC code 47463051060, which may be incorrectly assigned to a GCN. This NDC (47463051060—metformin) is assigned to GCN 71160. However, for other NDCs with the same generic drug name (metformin), route and GPI are assigned to GCN 89863. Which GCN is correct?

The NDC code 47463051060 (Metformin HCl Tab SR 24HR 500 MG) is incorrectly assigned to GCN 71160. The correct GCN is 89863.

This particular NDC was recycled to the medication metformin and therefore should have a GCN of 89863, rather than the previous GCN linked to the obsolete NDC.

IHA 2013

1.15.2014 Distribution of the Member's Rights and Responsibilities Statement May a delegate distribute the statement of members' rights and responsibilities?

Yes. Distribution of member rights and responsibilities statement by a delegate is acceptable. The organization must perform oversight to ensure that this requirement is met.

1.15.2014 Board Certification as Verification of Education and Training for Nurse Practitioners (NP) and Physician Assistants (PA) Is it acceptable to use ANCC and NCCPA board certification as verification of highest level of education for nurse practitioners and physician assistants?

Yes, if the organization can obtain written confirmation from the ANCC and NCCPA that they perform primary-source verification of the professional school training.

CVO 2013

12.20.2013 Supplemental Data Guidelines Have the dates been extended for primary source verification and final approval of supplemental data for P4P Measurement Year 2013?

Yes. Data collection and entry of all nonstandard and member-reported supplemental data must stop on March 3. Primary source verification and final approval must be completed by March 14, for member-reported supplemental data, and by March 28, for nonstandard supplemental data. Primary source verification may not occur before March 3 unless all supplemental data processes, collection and entry have stopped. Supplemental data approval and primary source verification may not occur, under any circumstances, before January 1 and receipt of the Roadmap.

IHA 2013

12.20.2013 Asthma Medication Ratio (AMR) Step 1 in the Event/Diagnosis section of the Eligible Population criteria refers to Table ASM-C for identifying asthma medication dispensing events. There is no Table ASM-C in the specification.

The table for identifying asthma medication dispensing events was inadvertently left out of the December 2, 2013, version of the MY 2013 manual. Table AMR-B is identical to Table ASM-C in HEDIS 2014 Volume 2.

IHA 2013

12.20.2013 Controlling Blood Pressure for People with Hypertension (CBPH) The CBPH measure is not listed in the P4P Value Set Directory. Where can we find the Value Sets for this measure?

The CBPH Value Sets can be found by filtering for Value Set Name in the P4P Value Sets to Codes tab of the P4P VSD file. The Value Sets for CBPH already exist as part of the CDC measure. The next release of the Value Set Directory will list the CBPH measure separately.

IHA 2013

12.20.2013 Evidence-Based Cervical Cancer Screening of Average-Risk, Asymptomatic Women (ECS) Step 3 of Rate 2 Underscreened does not specify what to do with the remaining population of women 30- 65 years with no hysterectomy who have no cervical cytology tests in the measurement year or two years prior to the measurement year and EITHER:
• Zero cervical cytology and HPV co-tests OR
• Two or more cervical cytology and HPV co-tests in the three or four years prior to the measurement year.

Could you clarify?

Per step 3 of Rate 3: Screened Too Frequently, a member with two or more cervical cytology and HPV co-tests in the third or fourth year prior to the measurement year is considered Screened Too Frequently.

IHA 2013

12.16.2013 General Guidelines If an organization finds an undated lab result in a progress note, can the progress note date be used as the lab result date?

No. An undated lab result may not be used for HEDIS reporting. To be eligible for use, the date the test was performed (e.g., the date the sample was drawn) or the result date (e.g., the date the lab calculated the result) must be documented.

HEDIS 2014

12.16.2013 Well-Child Visits in the Third, Fourth, Fifth and Sixth Years of Life Is a BMI growth chart sufficient for the physical requirement of the developmental history component?

No. Growth charts (height, weight, BMI or BMI percentile) do not meet criteria for physical developmental history for the W34 measure. The intent of the developmental history component (physical and mental) is to determine if the child was assessed for specific age-appropriate physical and mental developmental milestones, which are behaviors or physical skills seen in children as they grow and develop. For the W34 measure, examples of mental developmental milestones include ability to speak understandably, identify colors and define words appropriately. For the W34 measure, examples of physical developmental milestones include the ability to hop, throw a ball, draw and make a block tower. Documentation of "developing appropriately" or "normal development" meets criteria for both physical and mental development. Documentation of "growing appropriately" (without notation about "development") does not meet criteria for physical or mental developmental history.

Additional examples can be found in the Appendices of the Bright Futures Pocket Guide Guidelines for Health Supervision of Infants, Children, and Adolescents (http://brightfutures.aap.org/pdfs/bf3%20pocket%20guide_final.pdf).

HEDIS 2014

12.16.2013 General Guidelines Are HbA1c and LDL-C tests where the member collects a blood sample at home and sends it to a lab for results calculation allowed for HEDIS reporting?

No. Tests where the blood sample is collected by the member are considered self-administered tests and are not eligible for use in HEDIS reporting.

HEDIS 2014

12.16.2013 Cervical Cancer Screening In step 2 of the Administrative Specification, organizations identify women 30-64 years of age as of December 31 of the measurement year who had cervical cytology and a human papillomavirus (HPV) test, with service dates four or less days apart during the measurement year. When counting service dates, is the date of the cervical cytology considered day one or day zero of the four-day count?

The date of the cervical cytology is considered day zero. For example, if the service date for cervical cytology was December 1 of the measurement year, the HPV test must include a service date on or between December 1 and December 5 of the measurement year.

HEDIS 2014

11.15.2013 Volume 2 Technical Update In the Volume 2 Technical Update memo, the term "discharged alive" was replaced with "discharged" in measures that include discharges for AMI or CABG. Does this mean that members who died prior to discharge should be included in the measures?

No. Removal of the language "discharged alive" does not mean that deceased members should be included in measures. As with other HEDIS measures, deceased members who do not meet continuous enrollment or anchor date criteria should not be included in the measures Eligible Population. The term "discharged alive" was removed in order to make language consistent across AMI, CABG and PCI (the term had been removed from PCI in the July 1 release of the publication; NCQA received questions about why it was removed from PCI but not from AMI or CABG). In 2015, NCQA intends to remove the term "discharged alive" from all remaining references (i.e., PBH, FUH and all measure descriptions).

HEDIS 2014